Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 945

1.

Patient-Derived Xenograft Models of Breast Cancer and Their Application.

Murayama T, Gotoh N.

Cells. 2019 Jun 20;8(6). pii: E621. doi: 10.3390/cells8060621. Review.

2.

A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.

Wakabayashi H, Inaki A, Yoshimura K, Murayama T, Imai Y, Higuchi T, Jinguji M, Shiga T, Kinuya S.

Sci Rep. 2019 May 20;9(1):7625. doi: 10.1038/s41598-019-43880-6.

3.

Concepts and techniques: how to determine and identify the appropriate target segment in anatomical pulmonary segmentectomy?

Sato M, Murayama T, Nakajima J.

J Thorac Dis. 2019 Mar;11(3):972-986. doi: 10.21037/jtd.2019.02.83. Review.

4.

Redox-Active Zeolitic Transition Metal Oxides Based on ε-Keggin Units for Selective Oxidation.

Zhang Z, Ishikawa S, Zhu Q, Murayama T, Sadakane M, Hara M, Ueda W.

Inorg Chem. 2019 May 6;58(9):6283-6293. doi: 10.1021/acs.inorgchem.9b00502. Epub 2019 Apr 23.

PMID:
31013070
5.

Fatigue resistance of yttria-stabilized tetragonal zirconia polycrystal clasps for removable partial dentures.

Peng TY, Shimoe S, Tanoue N, Akebono H, Murayama T, Satoda T.

Eur J Oral Sci. 2019 Jun;127(3):269-275. doi: 10.1111/eos.12615. Epub 2019 Apr 19.

PMID:
31002752
6.

Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP4 receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cells.

Kurata N, Tokashiki N, Fukushima K, Misao T, Hasuoka N, Kitagawa K, Mashimo M, Regan JW, Murayama T, Fujino H.

Eur J Pharmacol. 2019 Jun 15;853:308-315. doi: 10.1016/j.ejphar.2019.04.014. Epub 2019 Apr 10.

PMID:
30980797
7.

The AMAGAMI technique: an easy technique to achieve precise stapling in thoracoscopic segmentectomy.

Sato M, Murayama T, Nakajima J.

J Thorac Dis. 2019 Jan;11(1):276-279. doi: 10.21037/jtd.2018.12.89.

8.

Active propagation of dendritic electrical signals in C. elegans.

Shindou T, Ochi-Shindou M, Murayama T, Saita EI, Momohara Y, Wickens JR, Maruyama IN.

Sci Rep. 2019 Mar 5;9(1):3430. doi: 10.1038/s41598-019-40158-9.

9.

Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells.

Sakai Y, Honda M, Matsui S, Komori O, Murayama T, Fujiwara T, Mizuno M, Imai Y, Yoshimura K, Nasti A, Wada T, Iida N, Kitahara M, Horii R, Toshikatsu T, Nishikawa M, Okafuji H, Mizukoshi E, Yamashita T, Yamashita T, Arai K, Kitamura K, Kawaguchi K, Takatori H, Shimakami T, Terashima T, Hayashi T, Nio K, Kaneko S; Hokuriku Liver Study Group.

Cancer Sci. 2019 Apr;110(4):1364-1388. doi: 10.1111/cas.13971. Epub 2019 Mar 27.

10.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

11.

Effects of intravesicular loading of a Ca2+ chelator and depolymerization of actin fibers on neurotransmitter release in frog motor nerve terminals.

Narita K, Suzuki N, Himi N, Murayama T, Nakagawa T, Okabe N, Nakamura-Maruyama E, Hayashi N, Sakamoto I, Miyamoto O, Kuba K.

Eur J Neurosci. 2019 Jan 27. doi: 10.1111/ejn.14353. [Epub ahead of print]

PMID:
30687962
12.

Conversion of Ca2+ oscillation into propagative electrical signals by Ca2+-activated ion channels and connexin as a reconstituted Ca2+ clock model for the pacemaker activity.

Saeki T, Kimura T, Hashidume K, Murayama T, Yamamura H, Ohya S, Suzuki Y, Nakayama S, Imaizumi Y.

Biochem Biophys Res Commun. 2019 Mar 5;510(2):242-247. doi: 10.1016/j.bbrc.2019.01.080. Epub 2019 Jan 24.

PMID:
30686532
13.

Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.

Tominaga K, Minato H, Murayama T, Sasahara A, Nishimura T, Kiyokawa E, Kanauchi H, Shimizu S, Sato A, Nishioka K, Tsuji EI, Yano M, Ogawa T, Ishii H, Mori M, Akashi K, Okamoto K, Tanabe M, Tada KI, Tojo A, Gotoh N.

Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):625-630. doi: 10.1073/pnas.1806851116. Epub 2018 Dec 26.

14.

Age at the time of hip fracture in patients with rheumatoid arthritis is 4 years greater than it was 10 years before, but is still younger than that of the general population.

Arai K, Suzuki N, Murayama T, Kondo N, Otsuka H, Koizumi M, Hosaka N, Fujikawa R, Yanabashi K, Sasage Y, Yoshida K, Kimura K, Higuchi K, Ajiro J, Endo N.

Mod Rheumatol. 2018 Dec 20:1-6. doi: 10.1080/14397595.2018.1561351. [Epub ahead of print]

PMID:
30572779
15.

Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.

Nishimura T, Nakata A, Chen X, Nishi K, Meguro-Horike M, Sasaki S, Kita K, Horike SI, Saitoh K, Kato K, Igarashi K, Murayama T, Kohno S, Takahashi C, Mukaida N, Yano S, Soga T, Tojo A, Gotoh N.

Oncogene. 2019 Apr;38(14):2464-2481. doi: 10.1038/s41388-018-0589-1. Epub 2018 Dec 7.

PMID:
30532069
16.

Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region.

Seira N, Yamagata K, Fukushima K, Araki Y, Kurata N, Yanagisawa N, Mashimo M, Nakamura H, Regan JW, Murayama T, Fujino H.

Pharmacol Res Perspect. 2018 Nov 11;6(6):e00441. doi: 10.1002/prp2.441. eCollection 2018 Dec.

17.

Phosphorylation and inhibition of ceramide kinase by protein kinase C-β: Their changes by serine residue mutations.

Takahashi H, Ashikawa H, Nakamura H, Murayama T.

Cell Signal. 2019 Feb;54:59-68. doi: 10.1016/j.cellsig.2018.11.008. Epub 2018 Nov 15.

PMID:
30448345
18.

Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.

Nishino S, Yamashita H, Tamori M, Mashimo M, Yamagata K, Nakamura H, Murayama T.

J Cell Biochem. 2019 Apr;120(4):5396-5408. doi: 10.1002/jcb.27818. Epub 2018 Nov 15.

PMID:
30444039
19.

Dysfunction of muscle contraction with impaired intracellular Ca2+ handling in skeletal muscle and the effect of exercise training in male db/db mice.

Eshima H, Tamura Y, Kakehi S, Nakamura K, Kurebayashi N, Murayama T, Kakigi R, Sakurai T, Kawamori R, Watada H.

J Appl Physiol (1985). 2019 Jan 1;126(1):170-182. doi: 10.1152/japplphysiol.00048.2018. Epub 2018 Nov 15.

PMID:
30433865
20.

Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Inui Y, Yakushijin K, Okamura A, Tanaka Y, Shinzato I, Nomura T, Ichikawa H, Mizutani Y, Kitao A, Kurata K, Kakiuchi S, Miyata Y, Sanada Y, Kitagawa K, Uryu K, Kawamoto S, Yamamoto K, Matsuoka H, Murayama T, Ito M, Minami H.

Transpl Infect Dis. 2019 Feb;21(1):e13024. doi: 10.1111/tid.13024. Epub 2018 Nov 27.

PMID:
30414316
21.

Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT).

Int J Hematol. 2019 Jan;109(1):131. doi: 10.1007/s12185-018-2557-5.

PMID:
30406327
22.

Surfactant-driven Amphoteric Doping of Carbon Nanotubes.

Nonoguchi Y, Tani A, Murayama T, Uchida H, Kawai T.

Chem Asian J. 2018 Dec 18;13(24):3942-3946. doi: 10.1002/asia.201801490. Epub 2018 Nov 15.

PMID:
30358121
23.

Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes.

Kutoh E, Wada A, Murayama T, Hayashi J.

Drugs R D. 2018 Dec;18(4):309-315. doi: 10.1007/s40268-018-0250-z.

24.

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M; Japan Study Group for Cell Therapy and Transplantation (JSCT).

Int J Hematol. 2019 Jan;109(1):107-114. doi: 10.1007/s12185-018-2543-y. Epub 2018 Oct 4. Erratum in: Int J Hematol. 2018 Nov 7;:.

PMID:
30284685
25.

A tryptophan residue in the caffeine-binding site of the ryanodine receptor regulates Ca2+ sensitivity.

Murayama T, Ogawa H, Kurebayashi N, Ohno S, Horie M, Sakurai T.

Commun Biol. 2018 Jul 23;1:98. doi: 10.1038/s42003-018-0103-x. eCollection 2018.

26.

A zeolitic vanadotungstate family with structural diversity and ultrahigh porosity for catalysis.

Zhang Z, Zhu Q, Sadakane M, Murayama T, Hiyoshi N, Yamamoto A, Hata S, Yoshida H, Ishikawa S, Hara M, Ueda W.

Nat Commun. 2018 Sep 17;9(1):3789. doi: 10.1038/s41467-018-06274-2.

27.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.

Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.

Hematol Oncol. 2018 Dec;36(5):792-800. doi: 10.1002/hon.2559. Epub 2018 Sep 19.

PMID:
30176173
28.

Development of a new doubly-labeled fluorescent ceramide probe for monitoring the metabolism of sphingolipids in living cells.

Wang Y, Kasahara J, Yamagata K, Nakamura H, Murayama T, Suzuki N, Nishida A.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3222-3226. doi: 10.1016/j.bmcl.2018.08.013. Epub 2018 Aug 15.

PMID:
30149971
29.

Influenza vaccine showed a good preventive effect against influenza-associated hospitalization among elderly patients, during the 2016/17 season in Japan.

Seki Y, Onose A, Murayama T, Koide C, Sugaya N.

J Infect Chemother. 2018 Nov;24(11):873-880. doi: 10.1016/j.jiac.2018.07.013. Epub 2018 Aug 9.

PMID:
30100400
30.

The challenges of characterising nanoparticulate catalysts: general discussion.

Arrigo R, Badmus K, Baletto F, Boeije M, Bowker M, Brinkert K, Bugaev A, Bukhtiyarov V, Carosso M, Catlow R, Chanerika R, Davies PR, Dononelli W, Freund HJ, Friend C, Gallarati S, Gates B, Genest A, Gibson EK, Hargreaves J, Helveg S, Huang H, Hutchings G, Irvine N, Johnston R, Lai S, Lamberti C, Macginley J, Marchant D, Murayama T, Nome R, Odarchenko Y, Quinson J, Rogers S, Russell A, Said S, Sermon P, Shah P, Simoncelli S, Soulantica K, Spolaore F, Tooze B, Torrente-Murciano L, Trunschke A, Willock D, Zhang J.

Faraday Discuss. 2018 Sep 3;208(0):339-394. doi: 10.1039/c8fd90014k. No abstract available.

PMID:
30095830
31.

Control of catalytic nanoparticle synthesis: general discussion.

Adishev A, Arrigo R, Baletto F, Bordet A, Bukhtiyarov V, Carosso M, Catlow R, Conway M, Davies J, Davies P, De Masi D, Demirci C, Edwards JK, Friend C, Gallarati S, Hargreaves J, Huang H, Hutchings G, Lai S, Lamberti C, Macino M, Marchant D, Murayama T, Odarchenko Y, Peron J, Prati L, Quinson J, Richards N, Rogers S, Russell A, Selvam P, Shah P, Shozi M, Skylaris CK, Soulantica K, Spolaore F, Tooze B, Torrente-Murciano L, Trunschke A, Venezia B, Walker J, Whiston K.

Faraday Discuss. 2018 Sep 3;208(0):471-495. doi: 10.1039/c8fd90015a. No abstract available.

PMID:
30091432
32.

Pulmonary extranodal marginal zone lymphoma that presented with macroglobulinemia and marked plasmacytic cell proliferation carrying the t(14;18)(q32;q21)/MALT1-immunoglobulin heavy-chain fusion gene in pleural fluid.

Akasaka T, Kishimori C, Maekawa F, Takeoka K, Hayashida M, Gomyo H, Murayama T, Ohno H.

J Clin Exp Hematop. 2018 Sep 19;58(3):141-147. doi: 10.3960/jslrt.18013. Epub 2018 Aug 8.

33.

[Rapid exacerbation of thrombotic microangiopathy accompanied by electrocardiogram abnormality leading to death].

Matsuoka N, Akaike M, Murayama T, Hashimoto H, Hirokawa Y, Inoki T.

Rinsho Ketsueki. 2018;59(7):895-898. doi: 10.11406/rinketsu.59.895. Japanese.

PMID:
30078800
34.

Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2018 Dec;97(12):2529-2530. doi: 10.1007/s00277-018-3455-x.

PMID:
30054705
35.

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.

Ohmachi K, Tobinai K, Kinoshita T, Ishikawa T, Hatake K, Ichikawa S, Ohmine K, Kamitsuji Y, Choi I, Chou T, Tsukasaki K, Kumagai K, Taniwaki M, Uchida T, Kikukawa Y, Kubo K, Mihara K, Tsukamoto N, Izutsu K, Yoshida I, Ishida F, Usui N, Iida S, Murayama T, Ueda E, Kuriki H, Ando K.

Int J Hematol. 2018 Nov;108(5):499-509. doi: 10.1007/s12185-018-2497-0. Epub 2018 Jul 19.

PMID:
30027429
36.

Feasibility of High-dose Iodine-131-metaiodobenzylguanidine Therapy for High-risk Neuroblastoma Preceding Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation: a Study Protocol.

Araki R, Nishimura R, Inaki A, Wakabayashi H, Imai Y, Kuribayashi Y, Yoshimura K, Murayama T, Kinuya S.

Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):161-166. doi: 10.22038/aojnmb.2018.29845.1203.

37.

Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2019 Jan;98(1):131-142. doi: 10.1007/s00277-018-3418-2. Epub 2018 Jul 5. Erratum in: Ann Hematol. 2018 Dec;97(12):2529-2530.

38.

Single-Step Construction of the anti-Deoxypropionate Motif from Propylene: Formal Total Synthesis of the Cuticular Hydrocarbons Isolated from Antitrogus parvulus.

Murayama T, Nozaki K.

Angew Chem Int Ed Engl. 2018 Aug 27;57(35):11394-11398. doi: 10.1002/anie.201804711. Epub 2018 Jul 26.

PMID:
29953709
39.

Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes.

Kutoh E, Wada A, Murayama T, Hayashi J.

Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):185-190. doi: 10.4103/ijem.IJEM_578_17.

40.

Thoracoscopic stapler-based "bidirectional" segmentectomy for posterior basal segment (S10) and its variants.

Sato M, Murayama T, Nakajima J.

J Thorac Dis. 2018 Apr;10(Suppl 10):S1179-S1186. doi: 10.21037/jtd.2018.01.31.

41.

Knockout of Ceramide Kinase Aggravates Pathological and Lethal Responses in Mice with Experimental Colitis.

Suzuki S, Tanaka A, Nakamura H, Murayama T.

Biol Pharm Bull. 2018;41(5):797-805. doi: 10.1248/bpb.b18-00051.

42.

The vinylogous Catellani reaction: a combined computational and experimental study.

Yamamoto Y, Murayama T, Jiang J, Yasui T, Shibuya M.

Chem Sci. 2017 Nov 30;9(5):1191-1199. doi: 10.1039/c7sc04265e. eCollection 2018 Feb 7.

43.

Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels.

Murayama T, Kurebayashi N, Ishigami-Yuasa M, Mori S, Suzuki Y, Akima R, Ogawa H, Suzuki J, Kanemaru K, Oyamada H, Kiuchi Y, Iino M, Kagechika H, Sakurai T.

Mol Pharmacol. 2018 Jul;94(1):722-730. doi: 10.1124/mol.117.111468. Epub 2018 Apr 19.

PMID:
29674523
44.

The anti-human cytomegalovirus drug tricin inhibits cyclin-dependent kinase 9.

Sadanari H, Fujimoto KJ, Sugihara Y, Ishida T, Takemoto M, Daikoku T, Murayama T.

FEBS Open Bio. 2018 Feb 20;8(4):646-654. doi: 10.1002/2211-5463.12398. eCollection 2018 Apr.

45.

New isocoumarins, naphthoquinones, and a cleistanthane-type diterpene from Nectria pseudotrichia 120-1NP.

Ariefta NR, Kristiana P, Aboshi T, Murayama T, Tawaraya K, Koseki T, Kurisawa N, Kimura KI, Shiono Y.

Fitoterapia. 2018 Jun;127:356-361. doi: 10.1016/j.fitote.2018.03.012. Epub 2018 Apr 3.

PMID:
29621598
46.

Tricin inhibits the CCL5 induction required for efficient growth of human cytomegalovirus.

Itoh A, Sadanari H, Takemoto M, Matsubara K, Daikoku T, Murayama T.

Microbiol Immunol. 2018 May;62(5):341-347. doi: 10.1111/1348-0421.12590.

PMID:
29603339
47.

Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese population.

Kurata K, Yakushijin K, Mizuno I, Gomyo H, Okamura A, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Sanada Y, Inui Y, Uryu K, Kawamoto S, Sugimoto T, Yamamoto K, Ito M, Matsuoka H, Murayama T, Minami H.

Int J Hematol. 2018 Jul;108(1):58-65. doi: 10.1007/s12185-018-2437-z. Epub 2018 Mar 22.

PMID:
29569120
48.

An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.

Fujimoto KJ, Nema D, Ninomiya M, Koketsu M, Sadanari H, Takemoto M, Daikoku T, Murayama T.

Antiviral Res. 2018 Jun;154:10-16. doi: 10.1016/j.antiviral.2018.03.006. Epub 2018 Mar 17.

PMID:
29559264
49.

No differences in objective dynamic instability during acceleration of the knee with or without subjective instability post-total knee arthroplasty.

Soeno T, Mochizuki T, Tanifuji O, Koga H, Murayama T, Hijikata H, Takahashi Y, Endo N.

PLoS One. 2018 Mar 16;13(3):e0194221. doi: 10.1371/journal.pone.0194221. eCollection 2018.

50.

Erratum to 'Inhibition of human cytomegalovirus replication by tricin is associated with depressed CCL2 expression' [Antiviral Research (2017) 15-19].

Akai Y, Sadanari H, Takemoto M, Uchide N, Daikoku T, Mukaida N, Murayama T.

Antiviral Res. 2018 Mar;151:105. doi: 10.1016/j.antiviral.2018.02.008. No abstract available.

PMID:
29519616

Supplemental Content

Loading ...
Support Center